Redhill Biopharma Ltd. ADR (RDHL) 14-day ATR is 0.04: This Stock is Set to Soar Above its Peers

Redhill Biopharma Ltd. ADR (NASDAQ: RDHL) open the trading on Thursday, with a bit cautious approach as it glided -5.69% to $0.45, before settling in for the price of $0.48 at the close. Taking a more long-term approach, RDHL posted a 52-week range of $0.26-$3.60.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 163.47%. This publicly-traded company’s shares outstanding now amounts to $29.70 million, simultaneously with a float of $29.55 million. The organization now has a market capitalization sitting at $13.49 million. At the time of writing, stock’s 50-day Moving Average stood at $0.5372, while the 200-day Moving Average is $0.8523.

Redhill Biopharma Ltd. ADR (RDHL) Ownership Facts and Figures

Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Drug Manufacturers – Specialty & Generic industry. Redhill Biopharma Ltd. ADR’s current insider ownership accounts for 0.50%, in contrast to 6.70% institutional ownership.

Redhill Biopharma Ltd. ADR (RDHL) Earnings and Revenue Records

So, what does the last quarter earnings report of the company that was made public on 6/29/2022 suggests? It has posted -$0.2 earnings per share (EPS) not meeting the forecaster’s viewpoint (set at -$0.03) by -$0.17. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.

Redhill Biopharma Ltd. ADR (NASDAQ: RDHL) Trading Performance Indicators

Let’s observe the current performance indicators for Redhill Biopharma Ltd. ADR (RDHL). It’s Quick Ratio in the last reported quarter now stands at 0.78. The Stock has managed to achieve an average true range (ATR) of 0.04. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 0.38.

In the same vein, RDHL’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -3.16.

Technical Analysis of Redhill Biopharma Ltd. ADR (RDHL)

[Redhill Biopharma Ltd. ADR, RDHL] recent stats showed that its last 5-days Average volume was poorer than the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 11.47% While, its Average True Range was 0.0351.

Raw Stochastic average of Redhill Biopharma Ltd. ADR (RDHL) in the period of the previous 100 days is set at 4.85%, which indicates a major rise in contrast to 2.31% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 62.55% that was lower than 268.04% volatility it exhibited in the past 100-days period.